Backed by six Peer Reviews VeinViewer can help Improve Safety Practices
MEMPHIS, Tenn. – (October 7, 2014) – Christie Medical Holdings, a global leader in mobile vein imaging systems, will exhibit its sixth generation VeinViewer® at the Emergency Nurses Association(ENA) Annual Conference “Safe Practice Safe Care,” Oct 9-11, at booth #605 at the Indiana Convention Center. VeinViewer can be an essential device in emergency departments where time is critical.
VeinViewer uses near-infrared light, DLP® technologies, and exclusive technology such as Active Vascular Imaging Navigation (AVIN™) to create a digital image of patient vasculature in real time. For patients with Difficult Venous Access (DVA), VeinViewer is the only vein finder on the market to provide pre-, during, and post-access information throughout the entire vascular access procedure, allowing emergency staff to assess and act quickly. VeinViewer’s TrueView accuracy helps clinicians find the optimal access point and vessel target, while the device’s patented Real-time Df² imaging allows medical staff to navigate curves in vessels, confirm patent IV, react and adjust the technique to help ensure successful catheter placement. In post-assessment procedures, clinicians can assess the patency of the vessel to help avoid complications.
Overall, VeinViewer can help improve first stick success by up to 100 percent, reduce medically unnecessary PICC lines by over 30 percent, increase patient satisfaction and provide a return on investment to hospitals.
Powerful Results from St. Elizabeth Hospital
St. Elizabeth Healthcare in Kentucky revealed the results of a quality improvement study where when VeinViewer was used, a record number of medically unnecessary PICC lines were avoided, resulting in less pain for the patient, an increase in patient satisfaction and yearly savings of more than $200,000. Read more.
In its “Recommendations for Improving Safety Practices with Short Peripheral Catheters” position paper, the seven-member task force of infusion therapy experts from the Infusion Nurses Society recommended to “incorporate vein visualization technology as a routine strategy for patients with difficult or poor venous access. Visualization technology can improve success rates, decrease unsuccessful insertion attempts, and improve patient satisfaction.” Read more.
To learn more about Christie vein finding devices: VeinViewer Vision2, VeinViewer VisionXTND and VeinViewer Flex, please visit www.christiemed.com.
About Christie Medical Holdings, Inc.
Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit www.christiemed.com.
Follow us on Twitter @christiemed
Christie® is a trademark of Christie Digital Systems USA, Inc., registered in the United States of America and certain other countries.
DLP® is a registered trademark of Texas Instruments.